In regions of the world where trachoma is endemic it is a chronic, progressive disease with two overlapping phases. The inflammatory phase, indicative of active infection with ongoing transmission is found most often in children under the age of 10 years. The cicatricial phase, a consequence of chronic granulomatous inflammation, begins in childhood but does not usually become severe until later in adult life. The severity of scarring, and risk of subsequent blindness, is a function of the intensity and duration of the previous inflammatory phase. As such, the relative degree or severity of inflammation in a community is considered to be an excellent predictor of future risk of blindness in a population.
Many grading schemes have been devised over the last 50 years more accurately to classify persons or communities with varying severity of trachomatous inflammation. These have grown increasingly complex, using up to 22 signs for each eye with each sign scored from 0 to 3.' Even the current WHO Table  2 . Complete disagreement was defined in the present situation when one observer reported no inflammation while another reported severe. Each less severe disagreement was then weighted more heavily in a linear fashion with complete agreement (none-none, mild-mild, etc.) given full weight. All analyses were conducted by person (not by eye) using the severity of the worst eye as the measure of inflammation.
Results
The prevalence rates of inflammatory trachoma are The analysis of intraobserver reliability examined in study I is presented in Table 4 . The most consistent observer was the standard, with a kappa of 0-92; the graders ranged from 0*50 to 0*70. These kappa statistics are in the low to moderate range except for the standard, who showed excellent internal consistency.
Results for interobserver agreement are shown in Table 5 . Graders 1 and 2 show a consistent increase in agreement over time; both were in the 'acceptable agreement' range by the time of study III. Grader 3 had the highest agreement in studies I and II, but fell off sharply in study III. This may reflect diagnostic drift or the small sample size. In an effort to describe the agreement based on all the data, a weighted average kappa was calculated for each examiner. These overall kappas are 0-65, 0 62, and 0-62 for graders 1, 2, and 3 respectively. While there is no basic difference among the graders, they still show agreement that is less than the acceptable range.
Discussion
All epidemiological studies are subject to measurement variability, whether they involve clinical observations, laboratory analyses, or interview based responses. Two main sources of variation in data such as these are: (a) sampling variability, which, if no bias Assaad and Maxwell-Lyons reported on interobserver trials for 574 persons examined in Taiwan6 using a modification of the MacCallan classification. They found that, when two highly experienced ophthalmologists were compared, the percentage agreement was 68-3%. When we adjusted their findings for expected agreement, however, the weighted kappa was only 0-37 (95% confidence interval: 0-29, 0.46). Kupka and coworkers also used the same classification system for their work in Morocco.7 They examined 100 adults and 100 school children using two graders. The Our calculations on their published data show that intraobserver agreement was good, with kappas ranging from 0*72 to 094. Interobserver agreement was not as good, however. The kappa was 0.54 (95% CI: 0-45, 0.63) using the extension of the method for more than two observers. 4 The most recent work in this area has been done by Brilliant and others in the Nepal Blindness Survey." They conducted a rigorously designed assessment of observer variation for a variety of ocular conditions. Their trachoma grading system was a modification of the currently recommended WHO classification. Results revealed poor interobserver agreement for active inflammatory disease. Kappas for varying intensity levels ranged from 0*31 to 0-51 depending on whether inflammation was graded on a 4-point or 2-point scale. The kappa for overall intensity grade in the worst eye was 0-36. Despite using a simplified version of the current WHO classification scheme and well trained and experienced ophthalmologists, our results are little better than those previously reported. While we noted that graders 1 and 2 improved to an acceptable level over time, grader 3 showed significant diagnostic drift, which emphasises the importance of restandardising clinical observers during the course of a protracted observation period.
The present study confirms that the current system for grading inflammation is inadequate. A new system of classification is needed if accurate and reproducible clinical observations are to be obtained for use in epidemiological studies of trachoma.
